Bacterial Exacerbation of Chronic Bronchitis

• FDA approval · 2024-05-01
  FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)

  FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizin…

• FDA approval · 2022-01-31
  FDA Approved: CLARITHROMYCIN — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approved Alembic Pharmaceuticals' generic clarithromycin under Original Application ANDA210459. This expands access to clarithromycin as…

• FDA approval · 2016-07-26
  FDA Approved: MOXIFLOXACIN — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for moxifloxacin hydrochloride (MOXIFLOXACIN) from Fresenius Kabi USA, LLC, indicating a modificatio…

• FDA approval · 2013-06-05
  FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)

  FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…

• FDA approval · 2012-03-30
  FDA Approved: LEVOFLOXACIN — Original Application (Chartwell RX, LLC)

  FDA approved an original ANDA for Levofloxacin, a generic antibiotic, submitted by Chartwell RX, LLC. The approval enables a generic version…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-08-20
  FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)

  FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).